Literature DB >> 28617060

Levonorgestrel-releasing intrauterine system (LNG-IUS 12) for prevention of pregnancy for up to five years.

Anita L Nelson1.   

Abstract

INTRODUCTION: A new five-year low dose, smaller-framed, levonorgestrel-releasing intrauterine contraceptive system (LNG-IUS 12) has been introduced to complement the currently available systems. Areas Covered: This article will provide an overview of this new intrauterine system - its composition and its mechanisms of action as well as the results of the Phase II and III clinical trials of its efficacy, safety and tolerability. Expert Commentary: This new LNG-IUS 12 provides five-year contraceptive protection a pregnancy rate (less than 1%) in first year of use, which puts it into the top tier with the existing LNG-IUS 20 products; however, the LNG-IUS 12 does not have the high rates of amenorrhea often seen with the higher dose devices. On the other hand, this new IUD shares the smaller frame and narrower insertion tube with the lower dose LNG-IUS 8, but offers longer effective life.

Entities:  

Keywords:  Contraception; LNG-IUS 12; intrauterine contraception; kyleena; levonorgestrel-releasing intrauterine system; long acting reversible contraception

Mesh:

Substances:

Year:  2017        PMID: 28617060     DOI: 10.1080/17512433.2017.1341308

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  3 in total

1.  LNG-IUS combined with progesterone ameliorates endometrial thickness and pregnancy outcomes of patients with early-stage endometrial cancer or atypical hyperplasia.

Authors:  Fang Fang; Hao Xu; Ling Wu; Linyi Hu; Ying Liu; Yinnan Li; Chunhua Zhang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  Efficacy, Safety, and Tolerability of a New Low-Dose Copper and Nitinol Intrauterine Device: Phase 2 Data to 36 Months.

Authors:  David K Turok; Anita L Nelson; Clint Dart; Courtney A Schreiber; Kevin Peters; Mary Jo Schreifels; Bob Katz
Journal:  Obstet Gynecol       Date:  2020-04       Impact factor: 7.623

3.  Utility of the Levonorgestrel-Releasing Intrauterine System in the Treatment of Abnormal Uterine Bleeding and Dysmenorrhea: A Narrative Review.

Authors:  Paola Bianchi; Sun-Wei Guo; Marwan Habiba; Giuseppe Benagiano
Journal:  J Clin Med       Date:  2022-10-01       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.